生物利用度
多西紫杉醇
药物输送
药理学
药代动力学
化学
色谱法
紫杉醇
剂型
材料科学
医学
癌症
有机化学
内科学
作者
Youn Gee Seo,Dae Hwan Kim,Thiruganesh Ramasamy,Jeong Hwan Kim,Nirmal Marasini,Yu‐Kyoung Oh,Dong‐Wuk Kim,Jong Oh Kim,Chul Soon Yong,Jong Oh Kim,Han‐Gon Choi
标识
DOI:10.1016/j.ijpharm.2013.05.034
摘要
The main purpose of this study was to investigate the potential of self-nano-emulsifying drug delivery system (SNEDDS) in improving the bioavailability of docetaxel (DCT) and its chemotherapeutic effect. The DCT-loaded SNEDDS was prepared by employing rational blends of capryol 90, labrasol, and transcutol HP using ternary phase diagram. The liquid nano-emulsion was spray-dried into solid SNEDDS (D-SNEDDS) using an inert porous carrier, colloidal silica. The optimized formulation was characterized in terms of physico-chemical and pharmacokinetic parameters. Furthermore, anti-tumor efficacy of D-SNEDDS was compared with commercial marketed product, Taxotere®. The various compositions of SNEDDS were screened and found optimal at a volume ratio of 10/75/15 for capryol 90, labrasol, and transcutol HP, respectively. We observed a high oral bioavailability of 17% DCT for D-SNEDDS than compared to only 2.6% for pure DCT solution. Notably, D-SNEDDS exhibited an augmented anti-tumor efficacy with a reduced toxicity profile when compared with intravenously administered Taxotere®, the commercialized formulation of DCT. Taken together, D-SNEDDS could be a potential candidate for an oral dosage form of DCT with enhanced antitumor activity and reduced toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI